FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely cardiology, and can be used to assess the cardiovascular system in persons with hearing problems in adaptive swimming. Serum, magnesium is examined in people with hearing problems, in the context of adaptive swimming. Echocardioscopic examination and daily monitoring of the electrocardiogram are performed. With values in the serum of magnesium from 0.8 to 1.2 mmol/l, the absence of pathology in echocardioscopy and in the daily monitoring of the electrocardiogram, the condition of the cardiovascular system of people with hearing problems is assessed as satisfactory and continues the program of physical rehabilitation with the help of adaptive swimming. At magnesium values of not more than 0.7 mmol/l, the registration of small cardiac abnormalities during echocardioscopy, when recording daily monitoring of the electrocardiogram, migration of the supraventricular artificial pacemaker are recorded, along with supraventricular, ventricular extrasystole, abnormality of the processes of repolarization of the myocardium, the condition of people hearing problems is assessed as unsatisfactory and temporarily suspended from employment by adaptive swimming.
EFFECT: method allows effective, informative and accessible monitoring of the cardiovascular system in people with hearing problems, engaged in adaptive swimming by evaluating the complex of the most significant indicators.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COMPLEX ASSESSMENT OF CARDIOVASCULAR SYSTEM VALUES IN PHYSICALLY CHALLENGED PEOPLE | 2017 |
|
RU2672934C1 |
PHARMACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF CHRONIC DISORDERS OF VEGETATIVE REGULATION OF HEART RHYTHM AND METHOD OF PREVENTION AND TREATMENT BY MEANS OF PHARMACEUTICAL COMBINATION | 2012 |
|
RU2493836C1 |
METHOD OF COMPLEX EVALUATION OF CARDIOVASCULAR SYSTEM PARAMETERS IN ATHLETES | 2017 |
|
RU2652968C1 |
METHOD OF PREDICTING RISK OF DEVELOPMENT OF PAROXYSMAL STATES IN CHILDREN WITH PERINATAL AFFECTION OF CENTRAL NERVOUS SYSTEM | 2011 |
|
RU2476158C2 |
METHOD OF TREATING PATIENTS SUFFERING ARTERIAL HYPERTENSION | 2012 |
|
RU2508087C1 |
METHOD OF TREATING CARDIOVASCULAR PATIENTS AFTER SUFFERING ACUTE CORONARY SYNDROME AND CARDIOSURGICAL INTERVENTIONS | 2019 |
|
RU2715209C1 |
METHOD OF DIAGNOSING NONCORONARY MYOCARDIUM AFFECTION IN PATIENTS WITH PULMONARY TUBERCULOSIS | 2011 |
|
RU2475746C2 |
METHOD OF TREATING PATIENTS WITH CARDIOVASCULAR DISEASES | 2013 |
|
RU2543468C2 |
METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY HYPERTONIC DISEASE | 2011 |
|
RU2466706C2 |
THERAPY OF MITOCHONDRIAL INSUFFICIENCY IN UNDIFFERENTIATED FORMS OF CONNECTIVE TISSUE DYSPLASIA IN CHILDREN | 2006 |
|
RU2379038C2 |
Authors
Dates
2018-11-21—Published
2017-09-19—Filed